Your browser doesn't support javascript.
loading
Decreasing Opioid Use Postpartum: A Quality Improvement Initiative.
Rogers, Rebecca G; Nix, Michael; Chipman, Zachary; Breen, Michael; Dieterichs, Chad; Nutt, Stephanie; Moxham, Jamie; Chang, Patrick; Rathouz, Paul J; Robertson, Henry; Young, Amy.
Afiliación
  • Rogers RG; Departments of Women's Health, Surgery and Perioperative Care, and Population Health, Dell Medical School, University of Texas at Austin, and Analytics and Health Economics, Seton Healthcare Family, Austin, Texas.
Obstet Gynecol ; 134(5): 932-940, 2019 11.
Article en En | MEDLINE | ID: mdl-31599842
ABSTRACT

OBJECTIVE:

To estimate the effects of an inpatient initiative to decrease opioid use among women admitted to labor and delivery.

METHODS:

We created a multimodal pain power plan with standard therapeutic postpartum activity goals rather than pain goals, tiered order sets with scheduled administration of nonsteroidal antiinflammatory drugs (NSAIDs), and embedded changes into the electronic health record. Before the multimodal pain power plan launch, pain was assessed on a 10-point scale; women received NSAIDs for pain levels of 3 or less and opioids for pain levels higher than 3. For this analysis, we included women who delivered at 5 hospitals in the 10 months before and 12 months after the multimodal pain power plan launch. Women with prior substance use disorder or complicated deliveries were excluded and we stratified analyses into women who delivered vaginally compared with by cesarean. Opioid use was converted to morphine milligram equivalent (MME). Women rated pain control in 24-hour blocks using individually ascertained cutoffs. A multivariable regression analysis was performed, and adjusted odds ratios are reported.

RESULTS:

We compared the 6,892 women who delivered 10 months before the pain power plan launch to the 7,527 who delivered in the 12 months after the launch. The mean cohort age was 29.6±6.0 years; the majority (75%) were white. Risk of opioid use decreased by 26% among women who delivered vaginally (risk ratio [RR] 0.74; 95% CI [0.68, 0.81]) and 18% among women who delivered by cesarean (RR 0.82; 95% CI [0.72, 0.92]). Among women who received opioids, mean MME use decreased 21% (RR 0.79; 95% CI [0.70, 0.88]) and 54% (RR 0.46; 95% CI [0.35, 0.61]) in the vaginal and cesarean delivery groups, respectively. Fewer women reported acceptable pain levels, with decreases of 82-69% (P<.01) and 82-74% (P<.01) in the vaginal and cesarean delivery groups, respectively. Within the postlaunch cesarean delivery group, women also reported that they were less likely to have their pain well controlled on the Hospital Consumer Assessment of Healthcare Providers and Systems questionnaires (82% vs 62%, P <.01).

CONCLUSION:

A standardized multimodal pain power plan reduced opioid use among a large cohort of women admitted to labor and delivery in Central Texas. Despite meeting functional goals, some women reported increased pain during their hospital stay.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antiinflamatorios no Esteroideos / Analgesia Obstétrica / Dolor de Parto / Morfina / Trastornos Relacionados con Opioides Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Obstet Gynecol Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antiinflamatorios no Esteroideos / Analgesia Obstétrica / Dolor de Parto / Morfina / Trastornos Relacionados con Opioides Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Obstet Gynecol Año: 2019 Tipo del documento: Article
...